Abstract: An environmentally friendly can for containing a product includes a sealed container that contains the product and includes a polyester resin and a release mechanism to open the container and access the product. The polyester resin may be a furan resin selected from poly (ethylene 2, 5-furan dicarboxylate) (PEF), poly (butylene 2, 5-furan dicarboxylate) (PBF), poly (trim ethylene furan dicarboxylate) (PTF), poly (propylene 2, 5-furandicarboxylate) (PPF), and poly (neopentyl 2, 5-furandicarboxylate) (PNF); and/or a biodegradable polyester resin such as polyglycolic acid (PGA). The can may further include a generally cylindrical shell molded to have a sealed bottom and a straight wall that includes the resin; and a cap to seal the shell, the cap having the release mechanism and a rim that includes the resin; wherein the rim of the cap is bonded to the wall of the shell to releasably seal the product inside the can.

Abstract: A furan can for containing a product includes a sealed container that contains the product and includes a furan resin selected from the group consisting of: poly (ethylene 2,5-furan dicarboxylate) (PEF), poly (butylene 2,5-furan dicarboxylate) (PBF), poly (trim ethylene furan dicarboxylate) (PTF), poly (propylene 2,5-furandicarboxylate) (PPF), and poly (neopentyl 2,5-furandicarboxylate) (PNF); and a release mechanism to open the container and access the product. The can may further include a generally cylindrical shell molded to have a sealed bottom and a straight wall that includes the furan resin; and a cap to seal the shell, the cap having the release mechanism and a rim that includes the furan resin; wherein the rim of the cap is bonded to the wall of the shell to releasably seal the product inside the can.

Abstract: A bioplastic collapsible dispensing tube may include a collapsible tube having walls that include a bioplastic material; a distal end of the tube that is sealed; a proximal end of the tube, opposite the distal end, that has an opening; a nozzle on the opening; and a closure for the nozzle; wherein, when the closure is opened and the tube is collapsed, flowable material inside the tube is urged out of the nozzle; and the bioplastic material includes a bio resin selected from the group consisting of PEF, PBF, PTF, GPE, GPET, PLA, PDLA, PLLA, PHA, and PHBH. A method may include forming a tube and filling the tube with flowable material from the distal end.

Abstract: A furan can for containing a product includes a sealed container that contains the product and includes a furan resin selected from the group consisting of: poly (ethylene 2, 5-furan dicarboxylate) (PEF), poly (butylene 2, 5-furan dicarboxylate) (PBF), poly (trim ethylene furan dicarboxylate) (PTF), poly (propylene 2, 5-furandicarboxylate) (PPF), and poly (neopentyl 2, 5-furandicarboxylate) (PNF); and a release mechanism to open the container and access the product. The can may further include a generally cylindrical shell molded to have a sealed bottom and a straight wall that includes the furan resin; and a cap to seal the shell, the cap having the release mechanism and a rim that includes the furan resin; wherein the rim of the cap is bonded to the wall of the shell to releasably seal the product inside the can.

Abstract: Bio resin paperboard containers and cartons may include a bio resin laminated paperboard (BLP) that includes a sheet of paperboard having a first side and a second side opposite the first side; a first layer of bio resin laminated on the first side of the paperboard; and a second layer of bio resin laminated on the second side of the paperboard. Bio resins may include PEF, PBF, PTF, PPF, GPE, GPET, PLA, PDLA, PLLA, PHA, and PHBH. Methods may utilize a roll of BLP to form bio resin paperboard containers.

Abstract: Bio resin paperboard containers and cartons may include a bio resin laminated paperboard (BLP) that includes a sheet of paperboard having a first side and a second side opposite the first side; a first layer of bio resin laminated on the first side of the paperboard; and a second layer of bio resin laminated on the second side of the paperboard. Bio resins may include PEF, PBF, PTF, PPF, GPE, GPET, PLA, PDLA, PLLA, PHA, and PHBH. Methods may utilize a roll of BLP to form bio resin paperboard containers.

Abstract: A bioplastic collapsible dispensing tube may include a collapsible tube having walls that include a bioplastic material; a distal end of the tube that is sealed; a proximal end of the tube, opposite the distal end, that has an opening; a nozzle on the opening; and a closure for the nozzle; wherein, when the closure is opened and the tube is collapsed, flowable material inside the tube is urged out of the nozzle; and the bioplastic material includes a bio resin selected from the group consisting of PEF, PBF, PTF, GPE, GPET, PLA, PDLA, PLLA, PHA, and PHBH. A method may include forming a tube and filling the tube with flowable material from the distal end.

Abstract: Apparatus and methods are provided for analyzing an episode stored by an implantable medical device (IMD) using prior probability and conditional probability information to determine the likelihood of a particular diagnosis for a given stored episode. Certain embodiments include retrieving information about a stored episode from an IMD, including an episode metric, and retrieving domain expert information about potential diagnoses and episode metrics to determine the likelihood that the stored episode was due to a particular potential diagnosis. Certain embodiments also include retrieving patient information including a patient metric, such as patient demographics, or patient history. Certain embodiments of the invention include the ability to automatically or manually update or change the domain expert information.

Abstract: A system and method for post-processing of sensing data generated by a medical device that includes transmitting a plurality of stored sensing data generated by a medical device to an access device, the stored sensing data including sensed atrial events and sensed ventricular events. The access device determines, in response to the transmitted data, instances where the medical device identified a cardiac event being detected in response to the sensing data, and verifies, in response to the transmitted data, whether the determined instances should have been identified by the medical device as a cardiac event being detected.

Abstract: A method and system of post-processing of sensing data generated by a medical device that includes transmitting a plurality of stored sensing data generated by the medical device to an access device, the stored sensing data including sensed atrial events and sensed ventricular events. The access device determines, in response to the transmitted data, instances where the medical device identified a cardiac event being detected in response to the sensing data, and determines whether there is an abrupt onset of the cardiac event in response to the transmitted data.

Abstract: A system and method for determining oversensing during post-processing of sensing data generated by a medical device that includes transmitting a plurality of stored sensing data generated by the medical device to an access device, the stored sensing data including sensed atrial events and sensed ventricular events. The access device determines, in response to the transmitted data, instances where the medical device identified a cardiac event being detected in response to the sensing data, identifies and removes suspected far-field R-waves, and determines whether a signal including the removed suspected far-field R-waves is regular.

Abstract: A method and system for post-processing of sensing data associated with identification of a cardiac event by a medical device that includes transmitting a plurality of stored sensing data generated by the medical device to an access device, the stored sensing data including sensed atrial events and sensed ventricular events. The access device determines, in response to the transmitted data, instances where the medical device identified a cardiac event being detected in response to the sensing data, and generates a template in response to correlated morphologies of adjacent intervals prior to a detection interval corresponding to the cardiac being identified as the cardiac event and a morphology of the detection interval.

Abstract: A method and system of post-processing of sensing data generated by a medical device that includes transmitting a plurality of stored sensing data generated by the medical device to an access device, the stored sensing data including sensed atrial events and sensed ventricular events. The access device determines, in response to the transmitted data, instances where the medical device identified a cardiac event being detected in response to the sensing data, and determines, in response to the transmitted sensing data, whether one of the sensed ventricular events and the sensed atrial events is initiating conduction of a heart associated with the stored sensing data.

Abstract: A method and system of post-processing of sensing data generated by a medical device that includes transmitting a plurality of stored sensing data generated by the medical device to an access device, the stored sensing data including sensed atrial events and sensed ventricular events. The access device determines, in response to the transmitted data, instances where the medical device identified a cardiac event being detected in response to the sensing data, and determines a ratio of sensed atrial events to sensed ventricular events in response to the transmitted data.

Abstract: A method and system for determining undersensing during post-processing of sensing data generated by a medical device that includes transmitting a plurality of stored sensing data generated by the medical device to an access device, the stored sensing data including sensed atrial events and sensed ventricular events. The access device determines, in response to the transmitted data, instances where the medical device identified a cardiac event being detected in response to the sensing data, and determines whether one of a predetermined number of undersensing criteria have been met in response to the transmitted data.

Abstract: A method for identifying and classifying various types of oversensing in implantable medical devices (IMDs), such as implantable cardioverter defibrillators (ICDs), to assist a physician in choosing corrective action to reduce the likelihood of oversensing and inappropriate therapy delivery. Far-field electrogram (EGM) signals are analyzed to detect the occurrence of R-waves, and the result is compared to the number and pattern of R-waves sensed by the IMD and indicated on the marker channel. A marker channel with more sensed R-waves than indicated by analysis of the far-field EGM indicates the presence of oversensing, including double-counting of R-waves, T-wave oversensing, lead malfunction or failure, poor lead connections, noise associated with electromagnetic interference, non-cardiac myopotentials, etc.

Abstract: An implantable cardioverter defibrillator (ICD) senses ventricular depolarizations (R-waves) in an electrogram signal to detect a ventricular tachycardia or fibrillation episodes. The EGM signal is also monitored in real time for characteristics that uniquely identify instances of T-wave oversensing. The ICD determines whether detection of a tachycardia or fibrillation episode is appropriate based upon counts of each of the unique characteristics evidencing T-wave oversensing.

Abstract: A method and apparatus for detecting a lead-related condition that includes determining whether a first oversensing criteria is satisfied, determining whether a second oversensing criteria is satisfied, determining whether an impedance criteria has been satisfied, and generating an alert in response to more than one of the first oversensing criteria, the second over sensing criteria and the impedance criteria being satisfied.